Heidi Rütten

2.0k total citations · 1 hit paper
31 papers, 814 citations indexed

About

Heidi Rütten is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Heidi Rütten has authored 31 papers receiving a total of 814 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 14 papers in Surgery and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Heidi Rütten's work include Colorectal Cancer Surgical Treatments (14 papers), Colorectal and Anal Carcinomas (8 papers) and Colorectal Cancer Screening and Detection (5 papers). Heidi Rütten is often cited by papers focused on Colorectal Cancer Surgical Treatments (14 papers), Colorectal and Anal Carcinomas (8 papers) and Colorectal Cancer Screening and Detection (5 papers). Heidi Rütten collaborates with scholars based in Netherlands, United States and Sweden. Heidi Rütten's co-authors include Jannet C. Beukema, Vera Oppedijk, Caroline M. van Rij, Maurice J.C. van der Sangen, Patty H. Spruit, Janny G. Reinders, Maarten C.C.M. Hulshof, Dick J. Richel, Ate van der Gaast and J. Jan B. van Lanschot and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

Heidi Rütten

29 papers receiving 802 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Patterns of Recurrence After Surgery Alone Versus Preoperative Chemoradiotherapy and Surgery in the CROSS Trials

2014 340 citations Heidi Rütten et al. profile →

Peers

Heidi Rütten

SURGE

PRM

ONCOL

OTORH

PFM

Raymond L. Chai United States

Osamu Shiraishi Japan

Esther van Meerten Netherlands

Anne-Birgitte Jacobsen Norway

Kathryn Monson United Kingdom

P Zambon Italy

Tarje Onsøien Halvorsen Norway

Paola Pinnarò Italy

Seiichiro Mitani Japan

Michael A. Samuels United States

Raymond L. Chai United States

Heidi Rütten

325 ×0.7

SURGE

225 ×0.5

PRM

226 ×0.8

ONCOL

376 ×4.5

OTORH

65 ×0.9

PFM

Citations per year, relative to Heidi Rütten Heidi Rütten (= 1×) peers Raymond L. Chai

Countries citing papers authored by Heidi Rütten

Since Specialization

Citations

This map shows the geographic impact of Heidi Rütten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidi Rütten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidi Rütten more than expected).

Fields of papers citing papers by Heidi Rütten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heidi Rütten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidi Rütten. The network helps show where Heidi Rütten may publish in the future.

Co-authorship network of co-authors of Heidi Rütten

This figure shows the co-authorship network connecting the top 25 collaborators of Heidi Rütten. A scholar is included among the top collaborators of Heidi Rütten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heidi Rütten. Heidi Rütten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Witteman, Ben, N. Tjarda van Heek, Elske C. Gootjes, et al.. (2025). Bowel-Related Symptoms and Dietary Fiber Intake in Colorectal Cancer Survivors. JAMA Network Open. 8(11). e2542147–e2542147.

Gootjes, Elske C., Heidi Rütten, M.D. den Hartogh, et al.. (2025). Feasibility and clinical potential of exercise interventions during neoadjuvant chemoradiotherapy in patients with esophageal and rectal cancer. Journal of sport and health science. 14. 101060–101060.

Daamen, Lois A., Alice M. Couwenberg, Pètra M. Braam, et al.. (2024). Quality of life and clinical outcomes in rectal cancer patients treated on a 1.5T MR-Linac within the MOMENTUM study. Clinical and Translational Radiation Oncology. 45. 100721–100721. 2 indexed citations

Tijssen, Rob H.N., Heidi Rütten, Joost Nederend, et al.. (2024). Analysis of re-recurrent rectal cancer after curative treatment of locally recurrent rectal cancer. Radiotherapy and Oncology. 200. 110520–110520. 2 indexed citations

Rütten, Heidi, et al.. (2023). Locally recurrent rectal cancer and distant metastases: is there still a chance ofcure?. European Journal of Surgical Oncology. 49(9). 106865–106865. 6 indexed citations

Geerlings, Maartje J., Daniel von Rhein, Sofie H. Tolmeijer, et al.. (2022). Circulating Tumor DNA-Based Disease Monitoring of Patients with Locally Advanced Esophageal Cancer. Cancers. 14(18). 4417–4417. 17 indexed citations

Braam, Pètra M., et al.. (2021). Mesorectal shape variation in rectal cancer radiotherapy in prone position using a belly board. Physics and Imaging in Radiation Oncology. 19. 120–125. 1 indexed citations

Rütten, Heidi, C. Verhoef, Willem Jan van Weelden, et al.. (2021). Recurrent Endometrial Cancer: Local and Systemic Treatment Options. Cancers. 13(24). 6275–6275. 34 indexed citations

Peters, Femke P., Heidi Rütten, Maaike Berbée, et al.. (2020). Radiotherapy quality assurance for mesorectum treatment planning within the multi-center phase II STAR-TReC trial: Dutch results. Radiation Oncology. 15(1). 41–41. 1 indexed citations

10.

Jeene, Paul M., et al.. (2019). Low-Dose Versus High-Dose Radiation Therapy for the Palliation of Dysphagia From Esophageal Cancer: A Multicenter Retrospective Cohort Study. Practical Radiation Oncology. 10(4). e255–e263. 5 indexed citations

11.

Gurney‐Champion, Oliver J., Eva Versteijne, Astrid van der Horst, et al.. (2017). Addition of MRI for CT-based pancreatic tumor delineation: a feasibility study. Acta Oncologica. 56(7). 923–930. 20 indexed citations

12.

Rombouts, Anouk J. M., et al.. (2016). Treatment of Locally Recurrent Rectal Carcinoma in Previously (Chemo)Irradiated Patients. Diseases of the Colon & Rectum. 59(2). 148–156. 37 indexed citations

13.

Breugom, A.J., C.B.M. van den Broek, W. van Gijn, et al.. (2014). OC-0251: The value of postoperative chemotherapy for rectal cancer patients after preoperative(chemo)radiotherapy and TME. Radiotherapy and Oncology. 111. S96–S97. 1 indexed citations

14.

Breugom, A.J., C.B.M. van den Broek, W. van Gijn, et al.. (2013). The value of adjuvant chemotherapy in rectal cancer patients after preoperative radiotherapy or chemoradiation followed by TME-surgery: The PROCTOR/SCRIPT study. European Journal of Cancer. 49. 10 indexed citations

15.

Steenbergen, Liza N. van, Pieta Krijnen, V.E.P.P. Lemmens, et al.. (2010). Improved survival of colon cancer due to improved treatment and detection: a nationwide population-based study in The Netherlands 1989–2006. Annals of Oncology. 21(11). 2206–2212. 95 indexed citations

16.

Rütten, Heidi, L.A.M. Pop, Geert O. Janssens, et al.. (2010). Long-Term Outcome and Morbidity After Treatment With Accelerated Radiotherapy and Weekly Cisplatin for Locally Advanced Head-and-Neck Cancer: Results of a Multidisciplinary Late Morbidity Clinic. International Journal of Radiation Oncology*Biology*Physics. 81(4). 923–929. 56 indexed citations

17.

Sebag‐Montefiore, David, Heidi Rütten, Éric Rullier, et al.. (2009). Three-year survival result of CORE (Capecitabine, Oxaliplatin, Radiotherapy and Excision) study after post-operative chemotherapy in patients with locally advanced rectal adenocarcinoma. Ghent University Academic Bibliography (Ghent University). 3 indexed citations

18.

Steenbergen, Liza N. van, Heidi Rütten, G.J. Creemers, et al.. (2009). Large age and hospital-dependent variation in administration of adjuvant chemotherapy for stage III colon cancer in southern Netherlands. Annals of Oncology. 21(6). 1273–1278. 39 indexed citations

19.

Moerland, Elna, Gesina van Lijnschoten, James S. Wrobel, et al.. (2009). 6114 K-ras and B-raf mutation analysis has clinical value in stage III colon carcinoma. European Journal of Cancer Supplements. 7(2). 357–357. 1 indexed citations

20.

Sebag‐Montefiore, David, Gina Brown, Heidi Rütten, et al.. (2005). An international phase II study of Capecitabine, Oxaliplatin, Radiotherapy and Excision (CORE) in patients with MRI-defined locally advanced rectal adenocarcinoma. Interim results.. Ghent University Academic Bibliography (Ghent University). 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact